Inari Historical Income Statement

NARI Stock

USD 47.10 2.08 4.23%

Historical analysis of Inari Medical income statement accounts such as Interest Expense of 186.2 K can show how well Inari Medical performed in making a profits. Evaluating Inari Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Inari Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Inari Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Inari Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

About Inari Income Statement Analysis

Inari Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Inari Medical shareholders. The income statement also shows Inari investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Inari Medical Income Statement Chart

As of now, Inari Medical's Selling And Marketing Expenses is increasing as compared to previous years. The Inari Medical's current EBITDA is estimated to increase to about 7.5 M, while Interest Expense is projected to decrease to under 186.2 K.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Inari Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Inari Medical minus its cost of goods sold. It is profit before Inari Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Inari Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Inari Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.As of now, Inari Medical's Selling And Marketing Expenses is increasing as compared to previous years. The Inari Medical's current EBITDA is estimated to increase to about 7.5 M, while Interest Expense is projected to decrease to under 186.2 K.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	4.5M	7.6M	10.7M	11.3M
Interest Income	154K	1.9M	15.6M	16.4M

Depreciation And Amortization Interest Income

Inari Medical income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Non Operating Income Net Other
Net Interest Income		1.0	0.9	-0.76	0.7	0.88	0.71	0.7	0.7	0.05	0.16	0.06	0.69	0.41	0.91	0.7	0.92	0.36	0.87	0.16	0.95	0.71
Interest Income	1.0		0.89	-0.73	0.68	0.87	0.69	0.68	0.68	0.06	0.17	0.07	0.67	0.42	0.9	0.68	0.9	0.37	0.86	0.17	0.94	0.69
Depreciation And Amortization	0.9	0.89		-0.92	0.91	0.99	0.91	0.91	0.91	-0.04	0.07	-0.03	0.91	0.37	1.0	0.91	1.0	0.28	0.87	0.07	0.96	0.93
Interest Expense	-0.76	-0.73	-0.92		-0.87	-0.86	-0.86	-0.86	-0.87	0.19	0.04	0.17	-0.89	-0.21	-0.9	-0.88	-0.92	-0.15	-0.92	0.04	-0.88	-0.98
Selling General Administrative	0.7	0.68	0.91	-0.87		0.91	1.0	1.0	1.0	-0.03	0.06	-0.01	1.0	0.35	0.9	1.0	0.9	0.24	0.71	0.06	0.82	0.93
Selling And Marketing Expenses	0.88	0.87	0.99	-0.86	0.91		0.91	0.9	0.91	-0.03	0.06	-0.01	0.9	0.38	0.99	0.91	0.99	0.27	0.79	0.06	0.95	0.89
Total Revenue	0.71	0.69	0.91	-0.86	1.0	0.91		1.0	1.0	0.02	0.12	0.04	1.0	0.4	0.91	1.0	0.9	0.29	0.71	0.12	0.81	0.92
Gross Profit	0.7	0.68	0.91	-0.86	1.0	0.9	1.0		1.0	0.03	0.13	0.05	0.99	0.41	0.9	1.0	0.9	0.3	0.71	0.13	0.81	0.93
Other Operating Expenses	0.7	0.68	0.91	-0.87	1.0	0.91	1.0	1.0		-0.04	0.06	-0.02	1.0	0.34	0.91	1.0	0.9	0.23	0.72	0.06	0.82	0.93
Operating Income	0.05	0.06	-0.04	0.19	-0.03	-0.03	0.02	0.03	-0.04		0.98	1.0	-0.07	0.91	0.0	-0.04	-0.03	0.94	-0.15	0.98	-0.13	-0.07
Net Income From Continuing Ops	0.16	0.17	0.07	0.04	0.06	0.06	0.12	0.13	0.06	0.98		0.99	0.04	0.94	0.1	0.06	0.08	0.98	0.01	1.0	-0.02	0.07
Ebit	0.06	0.07	-0.03	0.17	-0.01	-0.01	0.04	0.05	-0.02	1.0	0.99		-0.04	0.92	0.01	-0.02	-0.01	0.94	-0.14	0.98	-0.12	-0.05
Research Development	0.69	0.67	0.91	-0.89	1.0	0.9	1.0	0.99	1.0	-0.07	0.04	-0.04		0.32	0.9	1.0	0.9	0.21	0.74	0.04	0.82	0.94
Ebitda	0.41	0.42	0.37	-0.21	0.35	0.38	0.4	0.41	0.34	0.91	0.94	0.92	0.32		0.41	0.34	0.38	0.98	0.22	0.94	0.27	0.32
Cost Of Revenue	0.91	0.9	1.0	-0.9	0.9	0.99	0.91	0.9	0.91	0.0	0.1	0.01	0.9	0.41		0.9	1.0	0.31	0.85	0.11	0.96	0.91
Total Operating Expenses	0.7	0.68	0.91	-0.88	1.0	0.91	1.0	1.0	1.0	-0.04	0.06	-0.02	1.0	0.34	0.9		0.9	0.23	0.72	0.06	0.82	0.93
Reconciled Depreciation	0.92	0.9	1.0	-0.92	0.9	0.99	0.9	0.9	0.9	-0.03	0.08	-0.01	0.9	0.38	1.0	0.9		0.29	0.88	0.09	0.97	0.92
Income Before Tax	0.36	0.37	0.28	-0.15	0.24	0.27	0.29	0.3	0.23	0.94	0.98	0.94	0.21	0.98	0.31	0.23	0.29		0.2	0.98	0.19	0.24
Total Other Income Expense Net	0.87	0.86	0.87	-0.92	0.71	0.79	0.71	0.71	0.72	-0.15	0.01	-0.14	0.74	0.22	0.85	0.72	0.88	0.2		0.02	0.9	0.84
Net Income	0.16	0.17	0.07	0.04	0.06	0.06	0.12	0.13	0.06	0.98	1.0	0.98	0.04	0.94	0.11	0.06	0.09	0.98	0.02		-0.01	0.07
Income Tax Expense	0.95	0.94	0.96	-0.88	0.82	0.95	0.81	0.81	0.82	-0.13	-0.02	-0.12	0.82	0.27	0.96	0.82	0.97	0.19	0.9	-0.01		0.84
Non Operating Income Net Other	0.71	0.69	0.93	-0.98	0.93	0.89	0.92	0.93	0.93	-0.07	0.07	-0.05	0.94	0.32	0.91	0.93	0.92	0.24	0.84	0.07	0.84

Click cells to compare fundamentals

Inari Medical Account Relationship Matchups

Inari Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Net Interest Income	(831.3K)	(651K)	(141K)	1.6M	15.4M	16.2M
Interest Income	89.1K	484K	154K	1.9M	15.6M	16.4M
Depreciation And Amortization	497.5K	1.5M	4.5M	7.6M	10.7M	11.3M
Interest Expense	920.5K	1.1M	295K	294K	196K	186.2K
Selling General Administrative	37.2M	89.4M	190.0M	291.9M	343.7M	176.5M
Selling And Marketing Expenses	90K	333K	344K	957K	1.2M	1.3M
Total Revenue	51.1M	139.7M	277.0M	383.5M	493.6M	247.8M
Gross Profit	45.2M	126.6M	252.2M	339.0M	428.8M	219.5M
Other Operating Expenses	50.3M	121.3M	266.1M	411.6M	497.3M	249.8M
Operating Income	801.5K	18.4M	6.7M	(28.1M)	(3.6M)	(3.8M)
Net Income From Continuing Ops	(1.2M)	13.8M	9.8M	(29.3M)	(1.6M)	(1.7M)
Ebit	801.5K	16.8M	6.5M	(26.4M)	(3.6M)	(3.8M)
Research Development	7.2M	18.4M	51.0M	74.2M	87.5M	44.4M
Ebitda	1.3M	18.2M	11.0M	(18.8M)	7.1M	7.5M
Cost Of Revenue	5.9M	13.1M	24.8M	44.5M	64.9M	68.1M
Total Operating Expenses	44.4M	108.1M	241.4M	367.1M	432.4M	221.5M
Reconciled Depreciation	613.5K	1.4M	4.3M	7.1M	10.7M	11.3M
Income Before Tax	(1.2M)	13.8M	10.7M	(26.2M)	4.2M	4.5M
Total Other Income Expense Net	(2.0M)	(4.6M)	4.0M	1.9M	7.9M	8.3M
Net Income Applicable To Common Shares	(1.2M)	13.8M	9.8M	(29.3M)	(26.3M)	(25.0M)
Net Income	(1.9M)	13.8M	9.8M	(29.3M)	(1.6M)	(1.7M)
Income Tax Expense	715.3K	(912K)	845K	3.1M	5.9M	6.2M

Currently Active Assets on Macroaxis

TLN	Talen Energy
TMUS	T Mobile
BABA	Alibaba Group Holding
APP	Applovin Corp
VTI	Vanguard Total Stock

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:

How To Invest In Inari

Details

Is Inari Stock a good investment?

Details

What is Inari Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.84)

Earnings Share

(1.29)

Revenue Per Share

9.901

Quarterly Revenue Growth

0.214

Return On Assets

(0.03)

The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inari Historical Income Statement

About Inari Income Statement Analysis

Inari Medical Income Statement Chart

Total Revenue

Gross Profit

Inari Medical income statement Correlations

Inari Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inari Medical income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	+ 1.0	Net Interest Income
Cost Of Revenue	+ 1.0	Depreciation And Amortization
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Total Revenue	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative

Non Operating Income Net Other	- 0.98	Interest Expense
Total Other Income Expense Net	- 0.92	Interest Expense
Reconciled Depreciation	- 0.92	Interest Expense
Interest Expense	- 0.92	Depreciation And Amortization
Cost Of Revenue	- 0.9	Interest Expense
Research Development	- 0.89	Interest Expense